|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
JPS5896026A
(ja)
|
1981-10-30 |
1983-06-07 |
Nippon Chemiphar Co Ltd |
新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
|
|
US4609546A
(en)
|
1982-06-24 |
1986-09-02 |
Japan Chemical Research Co., Ltd. |
Long-acting composition
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4606918A
(en)
|
1983-08-22 |
1986-08-19 |
Syntex (U.S.A.) Inc. |
Polyoxypropylene-polyoxyethylene block polymer based adjuvants
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
CA1292686C
(en)
|
1986-10-27 |
1991-12-03 |
Ze'ev Shaked |
Pharmaceutical compositions of recombinant interleukin-2 and formulation process
|
|
CA1294215C
(en)
|
1986-10-27 |
1992-01-14 |
Ze'ev Shaked |
Pharmaceutical compositions of recombinant beta-interferon and formulation processes
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
IE922436A1
(en)
|
1991-07-25 |
1993-01-27 |
Idec Pharma Corp |
Induction of cytotoxic t-lymphocyte responses
|
|
MY111880A
(en)
|
1992-03-27 |
2001-02-28 |
Smithkline Beecham Biologicals S A |
Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a
|
|
JP3626996B2
(ja)
|
1992-05-23 |
2005-03-09 |
グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム |
Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン
|
|
DE69313134T2
(de)
|
1992-06-25 |
1998-02-26 |
Smithkline Beecham Biolog |
Adjuvantien enthaltende impfstoffzusammensetzung
|
|
KR100310510B1
(ko)
|
1993-03-23 |
2002-07-04 |
장 스테판느 |
3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
|
|
CN1135181A
(zh)
|
1993-09-14 |
1996-11-06 |
Cytel有限公司 |
使用泛dr结合肽改变免疫应答
|
|
ES2197170T3
(es)
|
1993-11-04 |
2004-01-01 |
Innogenetics N.V. |
Epitopos de celulas t humanas inmunologicamente dominantes del virus de la hepatitis c.
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US5709995A
(en)
|
1994-03-17 |
1998-01-20 |
The Scripps Research Institute |
Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
|
|
DE69517521T2
(de)
|
1994-04-08 |
2001-03-08 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville |
Peptid aus dem inneren des hepatitis-c-virus brauchbar für die stimulation cytotoxischer t-lymphocyten und die diagnose des hcv-kontaktes
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
ATE296313T1
(de)
|
1996-03-21 |
2005-06-15 |
Epimmune Inc |
Hla-a2.1 bindende peptide und deren verwendung
|
|
DK0935662T3
(da)
|
1996-05-24 |
2006-03-06 |
Chiron Corp |
Fusionsprotein med multiple epitoper
|
|
US6566330B1
(en)
|
1996-10-22 |
2003-05-20 |
Medical University Of South Carolina Foundation Research Development |
Positively charged non-natural amino acids, methods of making and using thereof in peptides
|
|
GB9711990D0
(en)
|
1997-06-11 |
1997-08-06 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
KR100731820B1
(ko)
|
1998-10-05 |
2007-06-25 |
파멕사 에이/에스 |
치료적 백신화를 위한 새로운 방법
|
|
NO311807B1
(no)
*
|
1999-03-04 |
2002-01-28 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
|
|
JP2003509465A
(ja)
|
1999-07-19 |
2003-03-11 |
エピミューン， インコーポレイテッド |
ペプチドおよび核酸組成物を使用する、ｃ型肝炎ウイルスに対する細胞性免疫応答の誘導
|
|
US20020076415A1
(en)
|
1999-12-14 |
2002-06-20 |
Jing-Hsiung Ou |
Hepatitis C virus gene products
|
|
GB0005703D0
(en)
|
2000-03-09 |
2000-05-03 |
Alpharma As |
Compounds
|
|
ATE502952T1
(de)
|
2000-09-01 |
2011-04-15 |
Epimmune Inc |
Hla-bindungspeptide und ihre anwendungszwecke
|
|
NO314587B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV
|
|
NO314588B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
|
|
EP1195381A1
(de)
|
2000-09-28 |
2002-04-10 |
Immusystems GmbH |
CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope
|
|
GB0026094D0
(en)
|
2000-10-25 |
2000-12-13 |
Imp College Innovations Ltd |
Methods
|
|
ATE356385T1
(de)
|
2002-06-10 |
2007-03-15 |
Algonomics N V |
Verfahren zur vorhersage der bindungsaffinität der mhc-peptid-komplexe
|
|
US7569225B2
(en)
*
|
2002-08-12 |
2009-08-04 |
The Council Of The Queensland Institute Of Medical Research |
Immunogenic lipopeptides comprising T-helper and B-cell epitopes
|
|
EP1537418A2
(en)
|
2002-09-13 |
2005-06-08 |
Intercell AG |
Method for isolating hepatitis c virus peptides
|
|
NZ551180A
(en)
|
2004-06-01 |
2009-10-30 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
EP1652858A1
(en)
|
2004-10-28 |
2006-05-03 |
Innogenetics N.V. |
Peptides for inducing a CTL and/or HTL response to hepatitis C virus
|
|
US20080305044A1
(en)
|
2004-11-29 |
2008-12-11 |
Seattle Genetics, Inc. |
Engineered Antibodies and Immunoconjugates
|
|
US8252893B2
(en)
*
|
2005-01-31 |
2012-08-28 |
Board Of Trustees Of The University Of Arkansas |
CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
|
|
WO2008107400A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Genimmune N.V. |
Hcv polyepitope construct and uses thereof
|
|
CA2767063A1
(en)
|
2009-07-03 |
2011-01-06 |
Bionor Immuno As |
Novel therapeutic and diagnostic means
|
|
JP6069212B2
(ja)
*
|
2010-12-02 |
2017-02-01 |
ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ |
ペプチド骨格設計
|
|
JP6294076B2
(ja)
|
2011-01-06 |
2018-03-14 |
ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ |
多量体ペプチド
|
|
US8618303B2
(en)
*
|
2011-01-07 |
2013-12-31 |
Hoffmann-La Roche Inc. |
Pyrrolidine derivatives
|